NYLIM
TMO icon

New York Life Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

New York Life Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.9M Sell
53,568
-2,303
-4% -$1.11M 0.19% 102
2026
Q1 		$27.5M Buy
55,871
+1,379
+3% +$748K 0.23% 80
2025
Q4 		$31.6M Buy
54,492
+3,252
+6% +$1.84M 0.27% 69
2025
Q3 		$24.9M Sell
51,240
-153
-0.3% -$71.2K 0.22% 87
2025
Q2 		$20.8M Buy
51,393
+214
+0.4% +$89.5K 0.2% 100
2025
Q1 		$25.5M Sell
51,179
-155
-0.3% -$83.9K 0.26% 72
2024
Q4 		$26.7M Buy
51,334
+473
+0.9% +$260K 0.26% 70
2024
Q3 		$31.5M Sell
50,861
-1,651
-3% -$977K 0.31% 60
2024
Q2 		$29M Sell
52,512
-344
-0.7% -$197K 0.29% 61
2024
Q1 		$30.7M Sell
52,856
-2,017
-4% -$1.13M 0.31% 60
2023
Q4 		$29.1M Sell
54,873
-9,227
-14% -$4.47M 0.3% 62
2023
Q3 		$32.4M Sell
64,100
-901
-1% -$480K 0.35% 51
2023
Q2 		$33.9M Buy
65,001
+4,410
+7% +$2.38M 0.35% 50
2023
Q1 		$34.9M Sell
60,591
-168
-0.3% -$94.7K 0.39% 47
2022
Q4 		$33.5M Sell
60,759
-699
-1% -$370K 0.38% 44
2022
Q3 		$31.2M Sell
61,458
-2
-0% -$1.12K 0.38% 49
2022
Q2 		$33.4M Buy
+61,460
New +$33.8M 0.39% 47
2015
Q2 		– Sell
-2,642
Closed -$355K – 271
2015
Q1 		$355K Buy
2,642
+656
+33% +$84.6K 0.04% 138
2014
Q4 		$249K Buy
+1,986
New +$241K 0.03% 164

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

New York Life Investment Management's TMO Position: Q2 2026 in Review

New York Life Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 4.1% in Q2 2026, selling an estimated $1.11M and leaving 53,568 shares worth $26.9M. The position accounts for 0.19% of the portfolio, ranked #102.

New York Life Investment Management first reported a position in TMO in Q4 2014 and has held it in 19 quarters since. The position peaked at $34.9M in Q1 2023. 2,022 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • New York Life Investment Management held 53,568 shares of Thermo Fisher Scientific worth $26.9M as of Q2 2026.
  • New York Life Investment Management sold 2,303 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.11M.
  • Thermo Fisher Scientific made up 0.19% of New York Life Investment Management's portfolio in Q2 2026, its #102 holding.
  • New York Life Investment Management first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 19 quarters since.
  • New York Life Investment Management's Thermo Fisher Scientific position peaked at $34.9M in Q1 2023.
  • 2,022 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.